While China remains a cornerstone of our strategy, its pricing regulations limit revenue potential. Expanding into international markets, particularly the US, is critical to fully realize…
In Conversation
QIAGEN’s role in supporting Saudi Arabia’s Vision 2030 health transformation is to help strengthen prevention frameworks, ensure early detection, and provide solutions that empower the country’s…
Puerto Rico’s scientific expertise, advanced technology infrastructure, and skilled workforce make it a strategic hub for biopharmaceutical innovation, enabling us to shorten development timelines and improve…
By joining forces—across sectors, across regions—we can make a real difference in improving access to life-saving treatments for people around the world
We believe our strategic vision and leadership approach will ensure Biometas remains at the forefront of the CRO sector
I believe we are entering a new, exciting phase in China—a period of more maturity in the market
As we continue to prioritize the launch of innovative products in Saudi Arabia, we are also exploring broader investment opportunities, particularly in local production
Where the patients are, that’s where we must focus our commitment and innovation
From my perspective, international expansion is not just an aspiration but a necessary evolution
Vivian Zhang, Managing Director and General Manager of Merck China Healthcare, shares insights into the market’s strategic importance to the company and its current priorities in…
In a biotech company, it’s essential to explore different avenues initially, but once you identify what works best, focus your efforts there to create more value
I see this Center as the epicentre of research activity in Puerto Rico—a space where academics, students, technicians, and support staff come together with a common…
